Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.2%

10 terminated/withdrawn out of 855 trials

Success Rate

93.0%

+6.5% vs industry average

Late-Stage Pipeline

12%

100 trials in Phase 3/4

Results Transparency

2%

3 of 132 completed trials have results

Key Signals

158 recruiting3 with results6 terminated4 withdrawn

Enrollment Performance

Analytics

N/A
257(48.5%)
Phase 2
134(25.3%)
Phase 4
68(12.8%)
Phase 3
32(6.0%)
Phase 1
28(5.3%)
Early Phase 1
11(2.1%)
530Total
N/A(257)
Phase 2(134)
Phase 4(68)
Phase 3(32)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (855)

Showing 20 of 855 trials
NCT05384444Not ApplicableActive Not Recruiting

Effect of FMD on Colorectal Cancer Patients

Role: collaborator

NCT07644247Phase 4Not Yet Recruiting

STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump

Role: collaborator

NCT07644208Phase 2Not Yet Recruiting

PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative Hepatectomy

Role: lead

NCT07640906Not Yet Recruiting

AI-Assisted Chest-CT Reporting for Enhanced Speed and Quality (The DOUBLE-ACE Study)

Role: lead

NCT07558538Early Phase 1Recruiting

A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome

Role: lead

NCT07638683Phase 2Recruiting

A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).

Role: lead

NCT07452406Not ApplicableNot Yet Recruiting

Protocolized Weaning of High-Flow Nasal Cannula in Adult Patients

Role: collaborator

NCT06696820Phase 2Completed

Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke

Role: collaborator

NCT07634861Not ApplicableRecruiting

Evaluating a Text-Prompt AI Assistant for Chest CT Scans (AI-REPORT Study)

Role: lead

NCT07508956Phase 3Not Yet Recruiting

Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment

Role: lead

NCT07630454Phase 4Not Yet Recruiting

Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF

Role: collaborator

NCT07629921Active Not Recruiting

Multimodal AI for Precision Diagnosis of Esophageal Cancer

Role: lead

NCT07625735Not Yet Recruiting

MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric Cancer

Role: lead

NCT07621380Phase 4Not Yet Recruiting

Ertugliflozin's Effect on Heart Function in Diabetic Patients After Myocardial Infarction

Role: lead

NCT04513418Phase 3Active Not Recruiting

Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy

Role: collaborator

NCT07614061Phase 1Recruiting

Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer

Role: lead

NCT07616037Phase 2Recruiting

Efficacy of a GLP-1/FGF21 Dual Agonist for Treating PCOS

Role: lead

NCT07613996Recruiting

Impact of Hyperemic State on Angio-IMR Performance

Role: lead

NCT07616024Not ApplicableNot Yet Recruiting

Intravascular Ultrasound guidaNce versuS angIoGrapHy Guidance in Patients With ST-segment Elevation Myocardial Infarction

Role: lead

NCT07205419Not ApplicableNot Yet Recruiting

Eye-Tracking Communication Tool for Non-verbal ICU Patients

Role: lead